证券代码：300765 证券简称：新诺威 公告编号：2025-089 石药创新制药股份有限公司 关于使用部分闲置募集资金进行现金管理的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 石药创新制药股份有限公司（以下简称"公司"）于 2025 年 3 月 19 日召开第 六届董事会第二十二次会议、第六届监事会第十七次会议，于 2025 年 4 月 15 日召开 2024 年年度股东大会，会议审议并通过了《关于使用部分闲置募集资金 及自有资金进行现金管理的议案》。在不影响募集资金投资项目建设和公司正常 经营的情况下，公司及子公司使用不超过人民币 8.00 亿元（含本数）额度的闲 置募集资金及不超过人民币 8.00 亿元（含本数）的自有资金进行现金管理，投 资安全性高、流动性好的保本型产品（包括结构性存款、大额存单等），使用期 限自股东大会审议通过之日起 12 个月内有效。在上述额度及决议有效期内，业 务可循环滚动开展。具体内容详见巨潮资讯网（http://www.cninfo.com.cn）披露 的《关于使用部分闲置募集资金及自有资金进行现金管理的公告》（ ...

11月27日，新诺威盘中上涨2.03%，截至09:52，报33.75元/股，成交8671.37万元，换手率0.19%，总市 值474.05亿元。 截至10月31日，新诺威股东户数2.18万，较上期增加32.87%；人均流通股57116股，较上期减少 24.74%。2025年1月-9月，新诺威实现营业收入15.93亿元，同比增长7.71%；归母净利润-2404.89万元， 同比减少117.26%。 分红方面，新诺威A股上市后累计派现6.51亿元。近三年，累计派现5.00亿元。 机构持仓方面，截止2025年9月30日，新诺威十大流通股东中，香港中央结算有限公司位居第二大流通 股东，持股1778.22万股，相比上期减少321.69万股。中欧医疗健康混合A（003095）位居第三大流通股 东，持股1632.25万股，相比上期减少386.14万股。工银前沿医疗股票A（001717）位居第四大流通股 东，持股1400.01万股，相比上期增加200.01万股。汇添富创新医药混合A（006113）位居第五大流通股 东，持股1227.70万股，相比上期增加248.44万股。易方达创业板ETF（159915）位居第九大流通股东， ...

Core Viewpoint - The innovative drug sector is experiencing significant activity, with multiple companies reaching their daily price limits. Group 1: Company Performance - Zhongheng Group, Fuyuan Pharmaceutical, Hainan Haiyao, and Peking University Pharmaceutical have all hit the daily limit up [1] - Xinhua Pharmaceutical, ST Xiangxue, and Xinnowei are among the stocks with notable gains [1]

Group 1 - The core point of the article highlights the recent performance of XinNuoWei, which saw a 5.2% increase in stock price, reaching 33.39 CNY per share, with a total market capitalization of 46.899 billion CNY [1] - XinNuoWei's main business involves the research, production, and sales of functional foods, with revenue composition being 88.93% from functional foods and raw materials, 8.91% from biopharmaceuticals, and 2.16% from other sources [1] Group 2 - From the perspective of major fund holdings, data shows that Nuoan Fund has a significant position in XinNuoWei, with its Nuoan Selected Value Mixed A Fund increasing its holdings by 470,600 shares in the third quarter, now holding a total of 954,300 shares, which constitutes 4.9% of the fund's net value [2] - The Nuoan Selected Value Mixed A Fund has achieved a year-to-date return of 73.05%, ranking 163 out of 8,134 in its category, and a one-year return of 57.82%, ranking 429 out of 8,056 [2] - The fund manager, Tang Chen, has been in charge for 2 years and 343 days, with the fund's total asset size at 1.317 billion CNY, achieving a best return of 76.25% during his tenure [2]

Core Viewpoint - New Nuo Wei's stock price has shown a significant increase of 21.00% year-to-date, despite recent declines in the short term [1][2]. Company Overview - New Nuo Wei, established on April 5, 2006, and listed on March 22, 2019, is located in Shijiazhuang, Hebei Province. The company specializes in the research, production, and sales of functional foods, with revenue composition as follows: 88.93% from functional foods and raw materials, 8.91% from biopharmaceuticals, and 2.16% from other sources [1][2]. Financial Performance - For the period from January to September 2025, New Nuo Wei reported a revenue of 1.593 billion yuan, reflecting a year-on-year growth of 7.71%. However, the net profit attributable to the parent company was a loss of 24.049 million yuan, a decrease of 117.26% compared to the previous year [2][3]. Shareholder Information - As of October 31, the number of shareholders for New Nuo Wei increased by 32.87% to 21,800, with an average of 57,116 circulating shares per shareholder, down by 24.74% [2][3]. - The top ten circulating shareholders include significant institutional investors, with Hong Kong Central Clearing Limited holding 17.7822 million shares, a decrease of 3.2169 million shares from the previous period [3].

Core Viewpoint - New Nuo Wei's stock price has shown volatility, with a year-to-date increase of 21.98% but a significant decline of 33.69% over the past 60 days, indicating potential market concerns and investor sentiment shifts [1][2]. Financial Performance - For the period from January to September 2025, New Nuo Wei reported a revenue of 1.593 billion yuan, reflecting a year-on-year growth of 7.71%. However, the net profit attributable to shareholders was a loss of 24.049 million yuan, a decrease of 117.26% compared to the previous year [2]. - Since its A-share listing, New Nuo Wei has distributed a total of 651 million yuan in dividends, with 500 million yuan distributed over the last three years [3]. Shareholder and Market Activity - As of October 31, 2025, the number of shareholders for New Nuo Wei increased by 32.87% to 21,800, while the average number of circulating shares per person decreased by 24.74% to 57,116 shares [2]. - The stock has experienced significant trading activity, with a net outflow of 1.7647 million yuan in principal funds on November 19, 2025, and a notable presence on the trading leaderboard with a net buy of 39.7092 million yuan on June 6, 2025 [1]. Institutional Holdings - As of September 30, 2025, the second-largest circulating shareholder is Hong Kong Central Clearing Limited, holding 17.7822 million shares, a decrease of 3.2169 million shares from the previous period. Other notable shareholders include various mutual funds, with some increasing and others decreasing their holdings [3].

证券代码：300765 证券简称：新诺威 公告编号：2025-088 石药创新制药股份有限公司 关于使用部分闲置募集资金进行现金管理的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 石药创新制药股份有限公司（以下简称"公司"）于 2025 年 3 月 19 日召开第 六届董事会第二十二次会议、第六届监事会第十七次会议，于 2025 年 4 月 15 日召开 2024 年年度股东大会，会议审议并通过了《关于使用部分闲置募集资金 及自有资金进行现金管理的议案》。在不影响募集资金投资项目建设和公司正常 经营的情况下，公司及子公司使用不超过人民币 8.00 亿元（含本数）额度的闲 置募集资金及不超过人民币 8.00 亿元（含本数）的自有资金进行现金管理，投 资安全性高、流动性好的保本型产品（包括结构性存款、大额存单等），使用期 限自股东大会审议通过之日起 12 个月内有效。在上述额度及决议有效期内，业 务可循环滚动开展。具体内容详见巨潮资讯网（http://www.cninfo.com.cn）披露 的《关于使用部分闲置募集资金及自有资金进行现金管理的公告》（ ...

Core Viewpoint - The stock of XinNuoWei has experienced fluctuations, with a year-to-date increase of 24.73% but a significant decline of 35.29% over the past 60 days, indicating volatility in its market performance [1][2]. Company Overview - XinNuoWei, established on April 5, 2006, and listed on March 22, 2019, is based in Shijiazhuang, Hebei Province. The company focuses on the research, production, and sales of functional foods, with 88.93% of its revenue derived from functional foods and raw materials, 8.91% from biopharmaceuticals, and 2.16% from other sources [1][2]. Financial Performance - For the period from January to September 2025, XinNuoWei reported a revenue of 1.593 billion yuan, reflecting a year-on-year growth of 7.71%. However, the net profit attributable to the parent company was a loss of 24.0489 million yuan, a decrease of 117.26% compared to the previous year [2][3]. Shareholder Information - As of October 31, the number of shareholders for XinNuoWei increased by 32.87% to 21,800, with an average of 57,116 circulating shares per shareholder, down 24.74% from the previous period [2][3]. - The top ten circulating shareholders include significant institutional investors, with Hong Kong Central Clearing Limited holding 17.7822 million shares, a decrease of 3.2169 million shares from the previous period [3]. Dividend Distribution - Since its A-share listing, XinNuoWei has distributed a total of 651 million yuan in dividends, with 500 million yuan distributed over the past three years [3].

Group 1 - The People's Bank of China announced the November Loan Prime Rates (LPR) for one-year and five-year terms [2][3] - A total of 39 stocks will be unlocked this week, with a combined market value of approximately 951.97 billion yuan [2][3] - The highest market value of unlocked shares is from Ruijie Networks, amounting to 480.34 billion yuan, followed by Innovation New Materials at 105.42 billion yuan [4][5] Group 2 - The State Council held a meeting to enhance the adaptability of supply and demand for consumer goods, aiming to stimulate consumption and promote economic circulation [7] - The Ministry of Finance emphasized the importance of counter-cyclical and cross-cyclical adjustments to maintain economic support through various fiscal tools [8] - The China Securities Regulatory Commission is focusing on enhancing market resilience and attractiveness, aiming for higher quality and value in listed companies [9] Group 3 - The State Administration for Market Regulation released a draft for public consultation on antitrust compliance guidelines for internet platforms [10] - The Ministry of Commerce announced stricter management of second-hand car exports to prevent new cars from being exported under the guise of second-hand vehicles [11] - Yushun Technology has completed its IPO counseling, preparing for its public offering in China [12]

Core Viewpoint - A total of 32.91 billion shares with a market value of 28.164 billion yuan are set to be unlocked on November 17, involving 13 companies [1] Group 1: Unlocking Details - The companies with the highest unlocking volumes are Innovation New Materials, New World, and Yongshuntai, with unlocking shares of 2.287 billion, 291 million, and 266 million respectively [1] - In terms of market value, Innovation New Materials, New Nuo Wei, and Yongxi Electronics lead with unlocking values of 10.542 billion yuan, 5.34 billion yuan, and 3.97 billion yuan respectively [1] - The companies with the highest unlocking ratios relative to total share capital are New World, Innovation New Materials, and Yongshuntai, with ratios of 74.24%, 60.88%, and 52.97% respectively [1]